These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11261806

  • 21. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes.
    Bonnefont AB, Muñoz FJ, Inestrosa NC.
    FEBS Lett; 1998 Dec 18; 441(2):220-4. PubMed ID: 9883888
    [Abstract] [Full Text] [Related]

  • 22. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C, Inestrosa NC.
    J Neurochem; 2018 Feb 18; 144(4):443-465. PubMed ID: 29240990
    [Abstract] [Full Text] [Related]

  • 23. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC.
    Brain Res Brain Res Rev; 2004 Dec 18; 47(1-3):275-89. PubMed ID: 15572177
    [Abstract] [Full Text] [Related]

  • 24. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC.
    Mol Psychiatry; 2003 Feb 18; 8(2):195-208. PubMed ID: 12610652
    [Abstract] [Full Text] [Related]

  • 25. Wnt signaling involvement in beta-amyloid-dependent neurodegeneration.
    Inestrosa N, De Ferrari GV, Garrido JL, Alvarez A, Olivares GH, Barría MI, Bronfman M, Chacón MA.
    Neurochem Int; 2002 Nov 18; 41(5):341-4. PubMed ID: 12176076
    [Abstract] [Full Text] [Related]

  • 26. Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease.
    Duan S, Guan X, Lin R, Liu X, Yan Y, Lin R, Zhang T, Chen X, Huang J, Sun X, Li Q, Fang S, Xu J, Yao Z, Gu H.
    Neurobiol Aging; 2015 May 18; 36(5):1792-807. PubMed ID: 25771396
    [Abstract] [Full Text] [Related]

  • 27. Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease.
    Dinamarca MC, Sagal JP, Quintanilla RA, Godoy JA, Arrázola MS, Inestrosa NC.
    Mol Neurodegener; 2010 Jan 18; 5():4. PubMed ID: 20205793
    [Abstract] [Full Text] [Related]

  • 28. AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease.
    Nalivaeva NN, Turner AJ.
    Chem Biol Interact; 2016 Nov 25; 259(Pt B):301-306. PubMed ID: 27062894
    [Abstract] [Full Text] [Related]

  • 29. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
    Cottingham MG, Hollinshead MS, Vaux DJ.
    Biochemistry; 2002 Nov 19; 41(46):13539-47. PubMed ID: 12427014
    [Abstract] [Full Text] [Related]

  • 30. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers.
    Vargas JY, Ahumada J, Arrázola MS, Fuenzalida M, Inestrosa NC.
    Exp Neurol; 2015 Feb 19; 264():14-25. PubMed ID: 25450465
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
    Novotny R, Langer F, Mahler J, Skodras A, Vlachos A, Wegenast-Braun BM, Kaeser SA, Neher JJ, Eisele YS, Pietrowski MJ, Nilsson KP, Deller T, Staufenbiel M, Heimrich B, Jucker M.
    J Neurosci; 2016 May 04; 36(18):5084-93. PubMed ID: 27147660
    [Abstract] [Full Text] [Related]

  • 33. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ.
    PLoS One; 2007 Jul 25; 2(7):e652. PubMed ID: 17653279
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A new motif in the N-terminal of acetylcholinesterase triggers amyloid-β aggregation and deposition.
    Hou LN, Xu JR, Zhao QN, Gao XL, Cui YY, Xu J, Wang H, Chen HZ.
    CNS Neurosci Ther; 2014 Jan 25; 20(1):59-66. PubMed ID: 23981668
    [Abstract] [Full Text] [Related]

  • 37. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS.
    Int J Risk Saf Med; 2015 Jan 25; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [Abstract] [Full Text] [Related]

  • 38. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
    Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC.
    Exp Cell Res; 2004 Jul 01; 297(1):186-96. PubMed ID: 15194435
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.